NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
NRC HEALTH
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$20.47+0.32 (+1.59%)
Close on Oct 19, 2026
- Market cap
- $450.52M
- P/E (TTM)
- 0.4
- Dividend yield
- 2.54%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$0.52
+8.3% on the prior year
Consecutive increases
1 year
Every year since FY2024
Dividend yield
2.54%
Latest annual dividend ÷ share price
Payout ratio, FY2025
–
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $0.52 | +8.3% | $10.98M | – |
| FY2024 | $0.48 | -67.6% | $11.45M | – |
| FY2023 | $1.48 | +76.2% | $36.37M | – |
| FY2022 | $0.84 | +75.0% | $20.96M | – |
| FY2021 | $0.48 | +128.6% | $9.16M | – |
| FY2020 | $0.21 | -73.1% | $10.52M | – |
| FY2019 | $0.78 | – | $31.30M | – |
| FY2018 | – | – | $16.86M | 56.1% |
| FY2017 | – | – | $16.87M | 73.5% |
| FY2016 | – | – | $28.55M | 139.2% |
| FY2015 | – | – | $10.05M | 57.1% |
| FY2014 | – | – | – | – |
| FY2013 | – | – | $2.14M | 13.8% |
| FY2012 | $2.54 | +188.6% | $17.36M | 115.2% |
| FY2011 | $0.88 | +15.8% | $5.91M | 51.1% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.